The sample was submitted for investigation.The customer's high ft3 and ft4 results were reproduced.Upon further investigation, an interfering factor against the suru label was identified in the sample.This interference caused the high ft3 and ft4 results.Product labeling states: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.
|